We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.44%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$145M
AUM Growth
+$8.65M
(+6.4%)
Cap. Flow
+$1.37M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
22.7%
Holding
101
New
2
Increased
42
Reduced
31
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$1.64M |
| 2 |
VanEck Biotech ETF
BBH
|
+$519K |
| 3 |
State Street
STT
|
+$441K |
| 4 |
Mastercard
MA
|
+$274K |
| 5 |
Omnicom Group
OMC
|
+$267K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.93M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305K |
| 3 |
Wells Fargo
WFC
|
+$271K |
| 4 |
Amgen
AMGN
|
+$207K |
| 5 |
3M
MMM
|
+$175K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.79% |
| 2 | Technology | 13.37% |
| 3 | Consumer Staples | 10.59% |
| 4 | Financials | 10.11% |
| 5 | Healthcare | 9.49% |
Similar funds
SCV
RAG
TFP
AFA
CWM
MG
HWMG
AI
Boston Research & Management's Q2 2014 Portfolio in Review
As of Q2 2014, Boston Research & Management held 101 positions worth $145M, up 6.4% from $136M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4%. Boston Research & Management opened 2 new positions and exited 2, leaving the 101-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.
- Boston Research & Management's largest Q2 2014 buy was The Mosaic Company: 33,360 shares worth $1.65M.
- Boston Research & Management added most to VanEck Biotech ETF in Q2 2014, an estimated $519K increase.
- Boston Research & Management's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $305K.
- Boston Research & Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $1.93M.
- Boston Research & Management's ten largest holdings make up 23% of its $145M portfolio in Q2 2014.
- Boston Research & Management opened 2 new positions and closed 2 in Q2 2014.
- Boston Research & Management's portfolio value rose 6.4% quarter-over-quarter to $145M.
Based on Boston Research & Management's 13F filing for Q2 2014, filed 12 Aug 2014.